Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Obesity Management industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Vivus
Rhythm Pharmaceuticals, Inc
F Hoffmann-La Roche Ltd
AstraZeneca
Currax Pharmaceuticals LLC
GlaxoSmithKline plc
Teva Pharmaceutical Industries Ltd
Novo Nordisk
Sanofi-Aventis
Pfizer Inc
By Type:
Centrally Acting Drugs
Peripherally Acting Drugs
By Application:
Hospital Pharmacies
Retail Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Obesity Management Market Overview 2018-2029
-
1.1 China Obesity Management Industry Development Overview
-
1.2 China Obesity Management Industry Development History
-
1.3 China Obesity Management Industry Market Size (2018-2029)
-
1.4 China Obesity Management Market Analysis by Type from Production Side
-
1.4.1 China Obesity Management Production Volume, Production Value and Growth Rate of Centrally Acting Drugs (2018-2029)
-
1.4.2 China Obesity Management Production Volume, Production Value and Growth Rate of Peripherally Acting Drugs (2018-2029)
-
1.5 China Obesity Management Market Analysis by Application from Consumption End
-
1.5.1 China Obesity Management Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.2 China Obesity Management Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.6 China Obesity Management Market Analysis by Region
-
1.6.1 North China Obesity Management Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Obesity Management Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Obesity Management Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Obesity Management Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Obesity Management Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Obesity Management Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Obesity Management Market Size and Growth Rate from 2018-2029
Chapter 2 China Obesity Management Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Obesity Management Market Status and Competition at home and abroad in 2023
-
2.2.2 China Obesity Management Market Status and Competition Analysis in 2023
-
2.2.3 China Obesity Management Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Obesity Management Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Obesity Management Industry Development
Chapter 3 Obesity ManagementIndustry Chain Analysis
-
3.1 Obesity Management Industry Chain
-
3.2 Obesity Management Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Obesity Management Market
-
3.3 Obesity Management Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Obesity Management Market
Chapter 4 China Obesity Management Market, by Type
-
4.1 China Obesity Management Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Obesity Management Total Production Volume and Growth Rate from Production Side
-
4.5 China Obesity Management Production Volume and Growth Rate, by Type
-
4.5.1 China Obesity Management Production Volume and Growth Rate of Centrally Acting Drugs
-
4.5.2 China Obesity Management Production Volume and Growth Rate of Peripherally Acting Drugs
Chapter 5 China Obesity Management Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Obesity Management Total Market Size and Growth Rate from Consumption End
-
5.5 China Obesity Management Market Size and Growth Rate, by Application
-
5.5.1 China Obesity Management Market Size and Growth Rate of Hospital Pharmacies
-
5.5.2 China Obesity Management Market Size and Growth Rate of Retail Pharmacies
Chapter 6 China Obesity Management Market, by Region
-
6.1 China Obesity Management Production Volume and Production Value, by Region
-
6.2 China Obesity Management Sales Volume and Sales Value, by Region
Chapter 7 North China Obesity Management Market Analysis
-
7.1 North China Obesity Management Market, by Type
-
7.2 North China Obesity Management Market, by Application
Chapter 8 Central China Obesity Management Market Analysis
-
8.1 Central China Obesity Management Market, by Type
-
8.2 Central China Obesity Management Market, by Application
Chapter 9 South China Obesity Management Market Analysis
-
9.1 South China Obesity Management Market, by Type
-
9.2 South China Obesity Management Market, by Application
Chapter 10 East China Obesity Management Market Analysis
-
10.1 East China Obesity Management Market, by Type
-
10.2 East China Obesity Management Market, by Application
Chapter 11 Northeast China Obesity Management Market Analysis
-
11.1 Northeast China Obesity Management Market, by Type
-
11.2 Northeast China Obesity Management Market, by Application
Chapter 12 Southwest China Obesity Management Market Analysis
-
12.1 Southwest China Obesity Management Market, by Type
-
12.2 Southwest China Obesity Management Market, by Application
Chapter 13 Northwest China Obesity Management Market Analysis
-
13.1 Northwest China Obesity Management Market, by Type
-
13.2 Northwest China Obesity Management Market, by Application
Chapter 14 Company Profiles
-
14.1 Vivus
-
14.1.1 Vivus Company Profile
-
14.1.2 Vivus Obesity Management Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Rhythm Pharmaceuticals, Inc
-
14.2.1 Rhythm Pharmaceuticals, Inc Company Profile
-
14.2.2 Rhythm Pharmaceuticals, Inc Obesity Management Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 F Hoffmann-La Roche Ltd
-
14.3.1 F Hoffmann-La Roche Ltd Company Profile
-
14.3.2 F Hoffmann-La Roche Ltd Obesity Management Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Profile
-
14.4.2 AstraZeneca Obesity Management Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Currax Pharmaceuticals LLC
-
14.5.1 Currax Pharmaceuticals LLC Company Profile
-
14.5.2 Currax Pharmaceuticals LLC Obesity Management Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 GlaxoSmithKline plc
-
14.6.1 GlaxoSmithKline plc Company Profile
-
14.6.2 GlaxoSmithKline plc Obesity Management Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Teva Pharmaceutical Industries Ltd
-
14.7.1 Teva Pharmaceutical Industries Ltd Company Profile
-
14.7.2 Teva Pharmaceutical Industries Ltd Obesity Management Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Novo Nordisk
-
14.8.1 Novo Nordisk Company Profile
-
14.8.2 Novo Nordisk Obesity Management Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Sanofi-Aventis
-
14.9.1 Sanofi-Aventis Company Profile
-
14.9.2 Sanofi-Aventis Obesity Management Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Pfizer Inc
-
14.10.1 Pfizer Inc Company Profile
-
14.10.2 Pfizer Inc Obesity Management Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Obesity Management Industry Research Conclusions
-
15.2 Obesity Management Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Obesity Management Industry Market Size (2018-2029)
-
Figure China Obesity Management Production Volume, Production Value and Growth Rate of Centrally Acting Drugs (2018-2029)
-
Figure China Obesity Management Production Volume, Production Value and Growth Rate of Peripherally Acting Drugs (2018-2029)
-
Figure China Obesity Management Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Obesity Management Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure North China Obesity Management Market Size and Growth Rate from 2018-2029
-
Figure Central China Obesity Management Market Size and Growth Rate from 2018-2029
-
Figure South China Obesity Management Market Size and Growth Rate from 2018-2029
-
Figure East China Obesity Management Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Obesity Management Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Obesity Management Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Obesity Management Market Size and Growth Rate from 2018-2029
-
Figure Obesity Management Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Obesity Management Market Share by Type in 2018
-
Figure China Obesity Management Market Share by Type in 2023
-
Figure China Obesity Management Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Obesity Management Production Volume and Growth Rate of Centrally Acting Drugs (2018-2023)
-
Figure China Obesity Management Production Volume and Growth Rate of Peripherally Acting Drugs (2018-2023)
-
Figure China Obesity Management Market Share by Application in 2018
-
Figure China Obesity Management Market Share by Application in 2023
-
Figure China Obesity Management Total Market Size and Growth Rate from Consumption End
-
Figure China Obesity Management Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Obesity Management Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Table China Obesity Management Production Volume by Region (2018-2023)
-
Table China Obesity Management Production Volume Share by Region (2018-2023)
-
Figure China Obesity Management Production Volume Share by Region (2018-2023)
-
Table China Obesity Management Production Value by Region (2018-2023)
-
Table China Obesity Management Production Value Share by Region (2018-2023)
-
Figure China Obesity Management Production Value Share by Region (2018-2023)
-
Table China Obesity Management Sales Volume by Region (2018-2023)
-
Table China Obesity Management Sales Volume Share by Region (2018-2023)
-
Figure China Obesity Management Sales Volume Share by Region (2018-2023)
-
Table China Obesity Management Sales Value by Region (2018-2023)
-
Table China Obesity Management Sales Value Share by Region (2018-2023)
-
Figure China Obesity Management Sales Value Share by Region (2018-2023)
-
Table North China Obesity Management Production Volume by Type (2018-2023)
-
Table North China Obesity Management Production Volume Share by Type (2018-2023)
-
Figure North China Obesity Management Production Volume Share by Type (2018-2023)
-
Table North China Obesity Management Sales Volume by Application (2018-2023)
-
Table North China Obesity Management Sales Volume Share by Application (2018-2023)
-
Figure North China Obesity Management Sales Volume Share by Application (2018-2023)
-
Table Central China Obesity Management Production Volume by Type (2018-2023)
-
Table Central China Obesity Management Production Volume Share by Type (2018-2023)
-
Figure Central China Obesity Management Production Volume Share by Type (2018-2023)
-
Table Central China Obesity Management Sales Volume by Application (2018-2023)
-
Table Central China Obesity Management Sales Volume Share by Application (2018-2023)
-
Figure Central China Obesity Management Sales Volume Share by Application (2018-2023)
-
Table South China Obesity Management Production Volume by Type (2018-2023)
-
Table South China Obesity Management Production Volume Share by Type (2018-2023)
-
Figure South China Obesity Management Production Volume Share by Type (2018-2023)
-
Table South China Obesity Management Sales Volume by Application (2018-2023)
-
Table South China Obesity Management Sales Volume Share by Application (2018-2023)
-
Figure South China Obesity Management Sales Volume Share by Application (2018-2023)
-
Table East China Obesity Management Production Volume by Type (2018-2023)
-
Table East China Obesity Management Production Volume Share by Type (2018-2023)
-
Figure East China Obesity Management Production Volume Share by Type (2018-2023)
-
Table East China Obesity Management Sales Volume by Application (2018-2023)
-
Table East China Obesity Management Sales Volume Share by Application (2018-2023)
-
Figure East China Obesity Management Sales Volume Share by Application (2018-2023)
-
Table Northeast China Obesity Management Production Volume by Type (2018-2023)
-
Table Northeast China Obesity Management Production Volume Share by Type (2018-2023)
-
Figure Northeast China Obesity Management Production Volume Share by Type (2018-2023)
-
Table Northeast China Obesity Management Sales Volume by Application (2018-2023)
-
Table Northeast China Obesity Management Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Obesity Management Sales Volume Share by Application (2018-2023)
-
Table Southwest China Obesity Management Production Volume by Type (2018-2023)
-
Table Southwest China Obesity Management Production Volume Share by Type (2018-2023)
-
Figure Southwest China Obesity Management Production Volume Share by Type (2018-2023)
-
Table Southwest China Obesity Management Sales Volume by Application (2018-2023)
-
Table Southwest China Obesity Management Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Obesity Management Sales Volume Share by Application (2018-2023)
-
Table Northwest China Obesity Management Production Volume by Type (2018-2023)
-
Table Northwest China Obesity Management Production Volume Share by Type (2018-2023)
-
Figure Northwest China Obesity Management Production Volume Share by Type (2018-2023)
-
Table Northwest China Obesity Management Sales Volume by Application (2018-2023)
-
Table Northwest China Obesity Management Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Obesity Management Sales Volume Share by Application (2018-2023)
-
Table Vivus Company Profile
-
Table Vivus Obesity Management Revenue, Price and Gross (2018-2023)
-
Table Rhythm Pharmaceuticals, Inc Company Profile
-
Table Rhythm Pharmaceuticals, Inc Obesity Management Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Obesity Management Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Obesity Management Revenue, Price and Gross (2018-2023)
-
Table Currax Pharmaceuticals LLC Company Profile
-
Table Currax Pharmaceuticals LLC Obesity Management Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Obesity Management Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Industries Ltd Company Profile
-
Table Teva Pharmaceutical Industries Ltd Obesity Management Revenue, Price and Gross (2018-2023)
-
Table Novo Nordisk Company Profile
-
Table Novo Nordisk Obesity Management Revenue, Price and Gross (2018-2023)
-
Table Sanofi-Aventis Company Profile
-
Table Sanofi-Aventis Obesity Management Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Obesity Management Revenue, Price and Gross (2018-2023)
-
